Details of the Drug
General Information of Drug (ID: DM5MVF9)
| Drug Name |
6-nitroquipazine
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
6-nitroquipazine; 77372-73-7; 6-nitro-2-(piperazin-1-yl)quinoline; 6-Nitro-2-piperazin-1-yl-quinoline; 6-Nitro,2-(1-piperazinyl)quinoline; DU-24565; DU 24565; UNII-28M0X094BH; Quinoline,6-nitro-2-(1-piperazinyl)-; Quinoline, 6-nitro-2-(1-piperazinyl)-; CHEMBL41140; 28M0X094BH; 6-nitro-2-piperazin-1-ylquinoline; 6-Nitro-2-(1-piperazinyl)quinoline maleate salt; Lopac-Q-109; Biomol-NT_000101; AC1L1JF0; AC1Q1XW4; Lopac0_001010; SCHEMBL401156; AC1Q21C2; BPBio1_001389; DTXSID7044001; CTK5E4324; GGDBEAVVGFNWIA-UHFFFAOYSA-N; CHEBI:104164
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Structure |
![]() |
|||||
| 3D MOL | 2D MOL | |||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 258.279 | ||||
| Logarithm of the Partition Coefficient (xlogp) | 1.8 | |||||
| Rotatable Bond Count (rotbonds) | 1 | |||||
| Hydrogen Bond Donor Count (hbonddonor) | 1 | |||||
| Hydrogen Bond Acceptor Count (hbondacc) | 5 | |||||
| Chemical Identifiers |
|
|||||
| Cross-matching ID | ||||||
| Drug-Molecule Activity Atlas (DMA)NEW | Click to Jump to the Detailed DMA Information of This Drug | |||||
| Drug ADMET Endpoint Profile (DAE)NEW | Click to Jump to the Detailed DAE Information of This Drug | |||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||
Molecular Expression Atlas of This Drug
|
||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|


